The role of CUGBP1 in age-dependent changes of liver functions

Ageing Research Reviews

Volumn 11, Issue 4, 2012, Pages 442-449

  Jones, Karlie ^a   Timchenko, Lubov ^a   Timchenko, Nikolai A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; C EBP; Chromatin; CUGBP1; Epigenetic; Liver

Indexed keywords

INITIATION FACTOR 2; PROTEIN CUGBP1; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGING; CELL DIFFERENTIATION; COMPLEX FORMATION; FATTY LIVER; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER CANCER; LIVER CELL; LIVER FUNCTION; LIVER REGENERATION; LIVER SINUSOID; MYOTONIC DYSTROPHY; NONHUMAN; PARTIAL HEPATECTOMY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; TRANSLATION REGULATION;

AGING; ANIMALS; CONSERVED SEQUENCE; HUMANS; LIVER DISEASES; MICE; RNA-BINDING PROTEINS;

EUKARYOTA; MUS;

EID: 84866493475     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.02.007     Document Type: Review

References (80)

1. Achiron A., Barak Y., Magal N., Shonat M., Cohen M., Barar R., Gadoth N. Abnormal liver test in myotonic dystrophy. Journal of Clinical Gastroenterology 1998, 26:292-295.
2. Bae E.J., Kim S.G. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation. Molecular Pharmacology 2005, 3:660-669.
3. Baldwin B.R., Timchenko N.A., Zhanow C.A. EGF receptor stimulation activates the RNA binding protein, CUGBP1, and increases expression of C/EBPβ-LIP in mammary epithelial cells. Molecular and Cellular Biology 2004, 24:3682-3691.
4. Beisang D., Rattenbacher B., Vlasova-St Louis I.A., Bohjanen P. Regulation of CUG-Binding Protein 1 (CUGBP1) binding to target transcripts upon T cell activation. Journal of Biological Chemistry 2011, 10.1074/jbc.M111.291658.
5. Berrougui H., Khalil A. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity. Rejuvenation Research 2009, 12:117-126.
6. Bort R., Zaret K.S. The liver: pathology and pathobiology. Chapter 2, Embryonic Development of the Liver 2009, 17-27. Wiley-Blackwell, Wiley & Sons, LTD Production. 5th ed. M. Arias (Ed.).
7. Bucher N.L.R., Glinos M.N., Di Troi J.F. The influence of age upon the incorporation of thymidine-2C14 into the DNA of regenerating rat liver. Cancer Research 1964, 24:509-512.
8. Chipchase M.D., O'Neill M., Melton D.W. Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice. Hepatology 2003, 38:966-968.
9. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weisman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 43:760-764.
10. Cree M.G., Newcomer B.R., Katsanos C.S., Sheffield-Moore M., Chinkes D., Aarsland A., Urban R., Wolee R.R. Intramuscular and liver triglycerides are increased in elderly. Journal of Clinical Endocrinology and Metabolism 2004, 89:3864-3871.
11. Edwards J., Malaurie E., Kondratov A., Long J., de Moor C., Searle M.S., Emsey J. Sequence determinants for the tandem recognition of UGU and CUG rich RNA elements by two N-terminal RRMs of SELF1. Nucleic Acids Research 2011, 39:8638-8650.
12. Erion D.M., Yonemitsu S., Nie Y., Nagai Y., Gillum M.P., Hsiao J.J., Iwasaki T., Stark R., Weismann D., Yu X.X., Murray S.F., Bhanot S., Monia B.P., Hovath T.L., Gao Q., Samuel V.T., Shilman G.I. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proceedings of the National Academy Science of the United States 2009, 106:11288-11293.
13. Fausto N., Campbell J.S. The Liver: Pathology and Pathobiology. Chapter 36. Liver Regeneration 2009, 549-565. Wiley-Blackwell, Wiley & Sons, LTD Production. 5th ed.
14. Floreani A. Liver diseases in the elderly: an update. Digestive Diseases 2007, 25:138-143.
15. Fox J.T., Stover P.J. Mechanism of the internal ribosome entry site-mediated translation of serine hydroxymethyltransferase 1. Journal of Biological Chemistry 2009, 284:31085-31089.
16. Franzini M., Fornaciari I., Siciliano G., Volpi L., Ricci G., Marchi S., Gagliardi G., Baggiani A., Torraca F., Fierabracci V., Miccoli M., Pompella A., Emdin M., Paolicchi A. Serum gamma glutamyltransferase fractions in myotonic dystrophy type 1: differences with healthy subjects and patients with liver disease. Clinical Biochemistry 2010, 43:1246-1248.
17. Fry M., Silbe J., Loeb L.A., Martin G.M. Delayed and reduced cell replication and diminishing levels of DNA-polymerase alpha in regenerating liver of aging mice. Journal of Cellular Physiology 1984, 118:225-232.
18. Giovannini I., Chiarla C., Giuliante F., Vellone M., Ardito F., Nuzzo G. The relationship between albumin, other plasma proteins and variables, and age in the acute phase response after liver resections in man. Amino Acids 2006, 31:463-469.
19. Grisham J.W. The Liver: Pathology and Pathobiology. Chapter 1, Organisational Principles of the Liver 2009, 6-16. Wiley-Blackwell, Wiley & Sons, LTD Production. 5th ed. M. Arias (Ed.).
20. Guiraud-Dogan C., Huguet A., Gomes-Pereira M., Brisson E., Bassez G., Junien C., Gourdon G. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice. Biochimica et Biophisica Acta 2007, 1772:1183-1191.
21. Herranz D., Serrano M. Impact of Sirt1 on mammalian aging. Aging 2010, 2:315-316.
22. Huichalaf C., Sakai K., Jin B., Jones K., Wang G.-L., Schoser B., Schnider Gold C., Sarkar P., Pereira-Smith O., Timchenko N.A., Timchenko L.T. Expansion of CUG RNA repeats causes stress and inhibition of translation in Myotonic Dystrophy 1 (DM1) cells. FASEB Journal 2010, 10:3706-3719.
23. Jamieson H.A., Hilmer S.N., Cogger V.C., Warren A., Cheluvappa R., Abermethy D.R., Everit A.V., Fraser R., De Cabo R., Le Couteur D.G. Caloric restriction reduces age-related pseodocapillarization of the hepatic sinusoid. Experimental Gerontology 2007, 42:374-378.
24. Jin J., Iakova P., Wang G-L., Shi X., Haefliger S., Finegold M., Timchenko N.A. Epigenetic changes play critical role in age-associated dysfunction of the liver. Aging Cell 2010, 9:895-910.
25. Jin J., Iakova P., Jiang J., Medrano E.E., Timchenko N.A. The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology 2011, 54:898-998.
26. Jin J., Wang G.-L., Shi X., Darlington G.J., Timchenko N.A. The age-associated decline of GSK3β plays a critical role in the inhibition of liver regeneration. Molecular and Cellular Biology 2009, 29:3867-3880.
27. Jin J., Wang G.-L., Salisbury E., Timchenko L.T., Timchenko N.A. GSK3β-cyclin D3-CUGBP1-eIF2 pathway in aging and in myotonic dystrophy. Cell Cycle 2009, 15:2356-2359.
28. Jin J., Wang G-L., Timchenko L.T., Timchenko N.A. GSK3β and aging liver. Aging 2009, 6:582-585.
29. Jones K., Jin B., Huichalaf C., Sarkar P., Schneider-Gold C., Schoser B., Meola G., Shyi A.-B., Timchenko N.A., Timchenko L.T. RNA foci, CUGBP1 and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in Myotonic Dystrophies type 1 and type 2. American Journal of Pathology 2011, 5:2475-2489.
30. Iakova P., Awad S.S., Timchenko N.A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPα-mediated growth arrest. Cell 2003, 113:495-506.
31. Ishiko T., Inomata Y., Beppu T., Asonuma K., Okajima H., Takeitchi T., Baba H. Age and donor safety in living-donor liver transplantation in 110 consecutive cases at 1 institute. Experimental and Clinical Transplantation 2008, 6:190-193.
32. Ito Y., Sorensen K., Bethea N.W., Svistounov D., McCuskey M., Smedsrod B.H., McCuskey R.S. Age-related changes in the hepatic microcirculation in mice. Experimental Gerontology 2007, 42:789-797.
33. Karagiannides I., Thomou T., Tchkonia T., Pirtshalava T., Kypreos K., Cartwright A., Dalagiorgou D., Lash T.L., Farmer S.R., Timchenko N.A., Kirkland J.L. Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. Journal of Biological Chemistry 2006, 281:23025-23033.
34. Kim H.H., Gorospe M. GU-rich RNA: expanding CUGBP1 function, broadening mRNA turnover. Molecular Cell 2008, 29:151-152.
35. Kreiling J.A., Tamamori-Adachi M., Sexton A.N., Jeyapalan J.C., Munoz-Najar U., Peterson A.L., Manivannan J., Rogers E.S., Pchelintsev N.A., Adams P.D., Sedivy J.M. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell 2011, 10:292-304.
36. Kress C., Gautier-Courteille C., Osborne H.B., Babinet C., Paillard L. Inactivation of CUG-BP1/CELF1 causes growth, viability and spermatogenesis defects in mice. Molecular and Cellular Biology 2007, 27:1146-1157.
37. Krupczak-Hollis K., Wang X., Dennewitz M.B., Costa R.H. Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology 2003, 38:1552-1562.
38. Kuk J.L., Saunders T.J., Davidson L.E., Toss R. Age-related changes in total and regional fat distribution. Ageing Research Reviews 2009, 8:339-348.
39. Kuyumcu-Martinez N.M., Wang G.-S., Cooper T.A. Increased steady-state levels of CUGBP1 in myotonic dystrophy are due to PKC-mediated hyperphosphorylation. Molecular Cell 2007, 28:68-78.
40. Le Couteur D.G., Warren A., Cogger V., Smedsrod B., Sorensen K.K., De Cabo R., Fraser R., McCuskey R. Old age and the hepatic sinusoid. The Anatomical Record 2008, 291:672-683.
41. Lee J.E., Cooper T.A. Pathogenic mechanisms of myotonic dystrophy. Biochemical Society Transactions 2009, 37:1281-1286.
42. Marquis J., Paillard L., Audic Y., Cosson B., Danos O., Le Bec C., Osborne H.B. CUGBP1/SELF1 requires UGU-rich sequences for high affinity binding. Biochemical Journal 2006, 4000:291-301.
43. Michalopoulos G. Liver regeneration after partial hepatectomy. American Journal of Pathology 2010, 176:2-12.
44. Mori D., Sasagawa N., Kino Y., Ushiura S. Quantitative analysis of CUGBP1 binding to RNA repeats. Journal of Biochemistry 2008, 153:377-383.
45. Orellana D., Liu X., Wang G-L., Jin J., Iakova P., Timchenko N.A. Calmodulin controls liver proliferation via interactions with C/EBPβ-LAP and C/EBPβ-LIP. Journal of Biological Chemistry 2010, 285:23444-23456.
46. Ramsey K.M., Mills K.F., Satoh A., Imai S. Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell 2008, 7:78-88.
47. Rattenbacher B., Beisang D., Wiesner D.L., Jeschke J.C., von Hohenberg M., St Louis-Vlasova I.A., Bohjanen P.R. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Molecular and Cellular Biology 2010, 30:3970-3980.
48. Rayasam G.V., Tulasi V.K., Sodhi R., Davis J.A., Ray A. Glycogen synthase kinase 3: more than a namesake. British Journal of Pharmacology 2009, 156:885-898.
49. Salisbury E., Schoser B., Schneider-Gold C., Wang G.-L., Huichalaf C., Jin B., Sirito M., Sarkar P., Krahe R., Timchenko N.A., Timchenko L.T. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in DM2 patients. American Journal of Pathology 2009, 175:748-762.
50. Sarkar P.S., Han J., Reddy S. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues. Neuromuscular Disorders 2006, 14:497-506.
51. Schmucker D.L. Age-related changes in liver structure and functions: implications for disease?. Experimental Gerontology 2005, 40:650-659.
52. Schoser B., Timchenko L.T. Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Current Genomics 2010, 11:79-90.
53. Sedivy J.M., Banumathy G., Adams P.D. Aging by epigenetics-a consequence of chromatin damage?. Experimental Cell Research 2008, 314:1909-1919.
54. Sepe A., Tchkonia T., Thomou T., Zamboni M., Kirkland J.L. Aging and regional differences in fat cell progenitors. Gerontology 2011, 57:66-75.
55. Shieh K., Gilchrist J.M., Promrat K. Frequency and predictors of nonalcoholic fatty liver diseases in myotonic dystrophy. Muscle 2010, 41:197-201.
56. Tchkonia T., Morbeck D.E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosia S., Jensen M.D., Kirkland J.L. Fat tissue, aging, and cellular senescence. Aging Cell 2010, 9:667-684.
57. Teplova M., Song J., Gaw H.Y., Teplov A., Patel D.J. Structural insights into RNA recognition by the alternate-splicing regulator CUG-Binding Protein 1. Structure 2010, 18:1364-1377.
58. Timchenko N.A. Aging and liver regeneration. Trends in Endocrinology and Metabolism 2009, 20:171-176.
59. Timchenko N.A. Molecular pathology of the liver diseases. Chapter 19, Senescent Liver 2011, 279-290. Springer Science+Business Media, LLC, New York. S.P. Monga (Ed.).
60. Timchenko N.A., Harris T.E., Wilde M., Bilyeu T.A., Burgess-Beusse B.L., Finegold M.J., Darlington G.J. CCAAT/enhancer binding protein α regulates p21 protein and hepatocyte proliferation in newborn mice. Molecular and Cellular Biology 1997, 17:353-7361.
61. Timchenko N.A., Wang G-L., Timchenko L.T. CUG triplet repeat binding protein, CUGBP1, increases translation of C/EBPβ isoform, LIP, by interacting with the α and β subunits of eIF2. Journal of Biological Chemistry 2005, 280:20549-20557.
62. Timchenko N.A., Patel R., Iakova P., Cai Z.-J., Quan L., Timchenko L.T. Overexpression of CUG triplet repeat binding protein, CUGBP1, inhibits myogenesis. Journal of Biological Chemistry 2004, 279:13129-13139.
63. Timchenko L.T., Timchenko N.A., Caskey C.T., Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Human Molecular Genetics 1996, 5:115-123.
64. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Research 1996, 24:4407-4414.
65. Timchenko L.T., Salisbury E., Wang G.-L., Nguyen H.-D., Albrecht J.H., Hershey J.W.B., Timchenko N.A. Age-specific CUGBP1-eIF2 complex increases translation of C/EBPβ in old liver. Journal of Biological Chemistry 2006, 281:32806-32819.
66. Timchenko N.A., Welm A., Lu X., Timchenko L.T. CUG repeat binding protein (CUGBP1) interacts with the 5'region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms. Nucleic Acids Research 1999, 27:4517-4525.
67. Van den Broek W.J., Wansink D.G., Wieringa B. Somatic CTG-CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy. BMC Molecular Biology 2007, 8:1-8.
68. Vlasova I.A., Tahoe N.M., Fan D., Larsson O., Rattenbacher B., Sternjohn J.R., Vasdewani J., Karypis G., Reilly C.S., Bitterman P.B., Bohjanen P.R. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Molecular Cell 2008, 29:263-270.
69. Vlasova-St Louis I., Bohjanen P.R. Coordinate regulation of mRNA decay networking by GU-rich elements and SELF1. Current Opinion in Genetics & Development 2011, 21:444-451.
70. Wakabayashi H., Nishiyama Y., Ushiyama T., Maeba T., Maeta H. Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. Journal of Surgical Research 2002, 1006:246-253.
71. Wang G.-L., Shi X., Salisbury E., Sun Y., Albrecht J.H., Smith R.G., Timchenko N.A. Cyclin D3 maintains growth inhibitory activity of C/EBPα by stabilizing C/EBPα-cdk2 and C/EBPα-Brm complexes. Molecular and Cellular Biology 2006, 26:2570-2582.
72. Wang G.-L., Salisbury E., Shi X., Timchenko L.T., Medrano E.E., Timchenko N.A. HDAC1 cooperates with C/EBPα in the inhibition of liver proliferation in old mice. Journal of Biological Chemistry 2008, 283:26178-26196.
73. Wang G-L., Salisbury E., Shi X., Timchenko L.T., Medrano E.E., Timchenko N.A. HDAC1 promotes liver proliferation in young mice via interaction with C/EBPβ. Journal of Biological Chemistry 2008, 283:26179-26187.
74. Wang G.-L., Shi X., Haefliger S., Jin J., Major A., Iakova P., Finegold M., Timchenko N.A. Elimination of C/EBPα through the ubiquitin-proteasome system promotes the development of liver cancer in mice. Journal of Clinical Investigation 2010, 120:2549-2562.
75. Welm A.L., Mackey S.L., Timchenko L.T., Darlington G.J., Timchenko N.A. Translational induction of LIP during acute phase response leads to repression of C/EBP alpha mRNA. Journal of Biological Chemistry 2000, 275:27406-27413.
76. Woeller C.F., Fox J.T., Perry C., Stover P.J. A ferritin-responsive internal ribosome entry site regulates folate metabolism. Journal of Biological Chemistry 2007, 282:29927-29935.
77. Wynne H.A., Cope L.H., Kelly P., Whittimgham T., Edwards C., Kamali R. The influence of age, liver size and anantiomer concentrations of warfarin requirements. British Journal of Clinical Pharmacology 1995, 40:203-207.
78. Zahnow C.A. CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases. Expert Reviews in Molecular Medicine 2009, 11:1-34. Article author query zahnow ca [PubMed] [Google Scholar].
79. Zheng Y., Miskimins W.K. CUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry site. RNA Biology 2011, 8:365-371.
80. Zou M., Magalotti D., Bianchi G., Gueli C., Orlandini C., Grimaldi M., Marchesini G. Total functional hepatic blood flow decrease in parallel with ageing. Age and Ageing 1999, 28:29-33.